Skip to content

Common Stock at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$0
HRO
HarrowHROW
50M0.0%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
200M0.0%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$6K+20.0%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$0-100%
PBH
Prestige Consumer HealthcarePBH
$562K+0.4%

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$2.21B+58.2%
Enterprise value$1.63B+40.8%
P/S42.6×+19.1×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ocular Therapeutix's common stock?
Ocular Therapeutix (OCUL) reported common stock of $22K in Q1 2026.
How has Ocular Therapeutix's common stock changed year-over-year?
Ocular Therapeutix's common stock increased by 37.5% year-over-year, from $16K to $22K.
What is the long-term trend for Ocular Therapeutix's common stock?
Over 5 years (2020 to 2025), Ocular Therapeutix's common stock has grown at a 22.4% compound annual growth rate (CAGR), from $8K to $22K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).